Subdermal Contraceptive Implants Market Analysis of Key Players, End User, Demand and Consumption By 2027
Subdermal Contraceptive Implants Market: Introduction
Subdermal contraceptive implant is a tiny, thin rod about the size of a matchstick. The implant releases hormones slow and stable into the body to prevent pregnancy. Subdermal contraceptive implant helps to prevent pregnancy for one to five years. The protection period depends upon specific progestin and the type of polymer.
Read Report Overview – https://www.transparencymarketresearch.com/subdermal-contraceptive-implants-market.html
Advantages of subdermal contraceptive implant include long-term contraceptive action without requiring the provider’s or user’s attention, low dose of highly effective contraception without the use of estrogen, and fertility is readily reversible after the removal of implant.
Key Drivers and Restraints of Global Subdermal Contraceptive Implants Market
Rise in awareness about various birth control methods, introduction of several modern contraceptives in the market, and high per capita income are the major factors driving the global subdermal contraceptive implants market. According to the Guttmacher Institute, in 2018, nearly 21 million women needed publicly funded contraceptive services in the U.S. According to the Centers for Disease Control and Prevention, in 2017, around 214 million women of reproductive age in developing countries who want to avoid pregnancy are not using a modern contraceptive method.
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=75805
Recently, the UN collaborated with NGOs to provide contraceptive implants in underdeveloped countries at low price. This acts as a major driver of the market. Additionally, increase in the use of long-term contraception methods in developing countries and surge in awareness about contraception are likely to propel the global market.
Etonogestrel Implant to Witness Significant Demand
Based on type, the global subdermal contraceptive implants market can be segmented into etonogestrel implant, levonorgestrel implant, and others
The etonogestrel implant segment accounted for the largest share of the global subdermal contraceptive implants market in 2018. The segment is projected to dominate the global subdermal contraceptive implants market during the forecast period, as the implant is safe during breast feeding and improves symptoms of dysmenorrhea and endometriosis.
Request for Analysis on COVID-19 Impact on Subdermal Contraceptive Implants Market –https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=75805
Hospitals Segment to Witness Significant Growth
In terms of end-user, the global subdermal contraceptive implants market can be divided into hospitals, clinics, and others
The hospitals segment accounted for the largest market share in terms of revenue in 2018 and is anticipated to grow at a rapid pace during the forecast period. This can be attributed to increase in number of subdermal contraceptive implant procedures performed in hospitals.
North America to Dominate Global Subdermal Contraceptive Implants Market
In terms of region, the global subdermal contraceptive implants market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
North America dominated the global subdermal contraceptive implants market in 2018 and the trend is expected to continue during the forecast period. The region’s dominance can be attributed to increase in number of abortions, high number of unwanted pregnancies, presence of key market players in the region, greater affordability, and rise in demand for technologically advanced products. According to the Guttmacher Institute, in 2017, 862,000 abortions were carried out in U.S.
The market in Asia Pacific is likely to experience strong growth during the forecast period, owing to increase in adoption of new products, rise in awareness about contraceptives and STIs, and surge in disposable income in emerging countries such as India, China, and others.
Pre Book Subdermal Contraceptive Implants Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=75805<ype=S
Key Manufacturers Operating in Global Market
The global subdermal contraceptive implants market was highly fragmented in 2018. Key manufacturers operating in the global market are:
- Bayer AG
- Merck & Co. Inc.
- Shanghai Dahua Pharmaceutical Co., Ltd.
More Trending Reports by Transparency Market Research –
Veterinary Chemistry Analyzer Market: https://www.biospace.com/article/veterinary-chemistry-analyzer-market-veterinary-hospitals-to-represent-a-leading-segment/
Read our Case study at https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
